Mylan Pharmaceuticals Inc. recalls Fexofenadine HCl Tablets, USP, 60 mg, Allergy, Antihistamine, Indoor and Outdoor Allergies, Non-Drowsy, Original Prescri
Recalled April 15, 2015 · FDA recall D-0435-2015 · Mylan Pharmaceuticals
Hazard
Failed Impurities/Degradation Specifications: out of specification results for a related compound - a degradant of fexofenadine. · FDA Class III
Units
13,856 Bottles
Sold at
Nationwide
Description
Failed Impurities/Degradation Specifications: out of specification results for a related compound - a degradant of fexofenadine.
Product
Fexofenadine HCl Tablets, USP, 60 mg, Allergy, Antihistamine, Indoor and Outdoor Allergies, Non-Drowsy, Original Prescription Strength, a) 60 count Bottles, NDC 0378-0781-91, b) 500 count Bottles, NDC 0378-0781-05, Manufactured by: Mylan Pharmaceuticals Inc, Morgantown, WV, 26505, USA.
Manufacturer(s)
Mylan Pharmaceuticals Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →